CReDO Science Webinar – Cannabigerol (CBG) in Depth
Original price was: $99.$59Current price is: $59.
Dr. Russo, preeminent pharmacologist, neurologist and medical cannabis researcher, will present the findings of this important work. It is the first randomized placebo controlled clinical trail to investigate the effects of cannabigerol (CBG) on anxiety, mood, and stress and is a major step forward in demonstrating safety and efficacy of the molecule.
Credibility and Standards
MM411 certifications are designed to ensure that individuals and organizations meet specific standards of knowledge and competence in the field of medical cannabis. These certifications help establish credibility among healthcare providers, industry workers (budtenders) patients, and the medical community.
Comprehensive Education
The certification process typically involves comprehensive educational programs that cover various aspects of medical cannabis, including its medical uses, legal regulations, dosing, how to medicate, and potential interactions with other medications. This enables certified individuals to provide accurate and informed guidance to patients.
Enhanced Patient Care
By obtaining an MM411 certification, healthcare professionals and budtenders can enhance their ability to support patients effectively. This certification provides them with the tools and knowledge necessary to help patients navigate their medical cannabis journey, leading to improved treatment outcomes and overall patient satisfaction.
Course Description
Please join us for a webinar discussing the July 2024 peer-reviewed publication “Acute effects of cannabigerol on anxiety, stress, and mood: a double blind, placebo controlled, crossover, field trial”, by Carrie Cuttler, Amanda Stueber, Ziva D. Cooper & Ethan Russo.
Dr. Russo, preeminent pharmacologist, neurologist and medical cannabis researcher, will present the findings of this important work. It is the first randomized placebo controlled clinical trail to investigate the effects of cannabigerol (CBG) on anxiety, mood, and stress and is a major step forward in demonstrating safety and efficacy of the molecule.
This webinar will:
- Review the history and basic science of CBG.
- Review the recent Scientific Reports article by Cuttler et al. demonstrating anti-anxiety and anti-stress responses of CBG without impairment in a randomized controlled trial.
- Provide a greater understanding of the therapeutic benefits of CBG.